F3 tumor pieces from an ARID1A wildtype and an ARID1A mutant (homozygous ARID1A 1148* stop-gained mutation) PDX model (Figure S6B), were subcutaneously implanted in NSG mice, and were randomized into vehicle control and JQ1 treatment groups. This evidence concerns the gene ARID1A and neoplasm.